Home/KnolSights/Merger and Acquisitions/Adaptimmune Sells Cell Therapies to US WorldMeds for $55 Million
July 28, 2025

Adaptimmune Sells Cell Therapies to US WorldMeds for $55 Million

Abstract
Publication Reports